Patent ID: 8796316

Claim:
A method of treating or inhibiting tuberculosis or leishmaniasis, comprising administering to a subject a therapeutically effective amount of a pharmaceutical composition to treat or inhibit tuberculosis or leishmaniasis, wherein the pharmaceutical composition comprises an azole compound and a pharmaceutically acceptable carrier, and wherein the azole compound is a 1,2,3-triazole, or one of its salts, represented by the general formula VIII: where: X is “N” and the radicals of the triazole ring are represented by: R 1 ═CF 2 R 6 ; R 6 ═R 10 =alkyl; and where radical R n can be located in any one or in more than one of the carbon atoms of the aromatic ring, and is represented by a halogen, thereby treating or inhibiting tuberculosis or leishmaniasis.